Stay updated on Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page adds navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and clearly marks that recruitment has ended; the Intervention/Treatment label was standardized from 'Intervention / Treatment' and the revision note updated to v3.6.0 (removing v3.5.5).
    Difference
    0.4%
    Check dated 2026-06-13T17:39:45.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a small backend/content update without visible changes to the study information or navigation.
    Difference
    0.1%
    Check dated 2026-06-06T14:27:34.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page's revision identifier updated from v3.5.3 to v3.5.4, indicating a software update or patch was applied to the page; no substantive study details appear to be altered.
    Difference
    0.1%
    Check dated 2026-05-15T23:53:33.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    A minor update to the ClinicalTrials.gov page’s technical revision/version indicator (from v3.5.2 to v3.5.3) is displayed.
    Difference
    0.1%
    Check dated 2026-04-24T06:39:10.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision history updated: v3.5.2 added and v3.5.0 removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:49:07.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Added related topic 'Squamous cell carcinoma of the head and neck' and a Genetic and Rare Diseases Information Center (GARD) resource.
    Difference
    0.2%
    Check dated 2026-04-02T15:38:16.000Z thumbnail image

Stay in the know with updates to Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.